You are currently not logged in   |   [login]
In Focus

Gyros platform integrated into second, US-based, contract research organization. Radix BioSolutions adopts Gyrolab xP workstation for immunoassay development.

[more]

Gyros platform enters leading US Clinical Research Organization. CEDRA Corporation, a division of Worldwide Clinical Trials, invests in Gyrolab workstation.

[more]

Gyros platform ramps up immunoassay capacity at ICON Development Solutions
CRO purchases third Gyrolab Workstation

[more]
Events

 14th International Congress of Immunology

Kobe Convention center, Kobe, Japan, 23-27 August 2010 [more] [schedule a meeting]

BioProcess Internation Conference & Exhibition

Rhode Island Convention Center, Providence RI, USA, 21-23 September 2010 [more] [schedule a meeting]

Inaugural North American Gyrolab Seminar

Olde Mill Inn, Basking Ridge, New Jersey, 21-22 October 2010 [more] [schedule a meeting]
Accelerate your development of therapeutic proteins
Gyros is the world leader in automated
micro-immunoassays for therapeutic protein development.
• Optimize immunoassays within days
•

Permits four-log dynamic range with reduced

non-specific interactions
• Enables assay designs free from multiplexing ambiguity
• Uses only nanoliters of precious sample and reagents